Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Biomerica (BMRA) Operating Expenses (2016 - 2025)

Historic Operating Expenses for Biomerica (BMRA) over the last 16 years, with Q4 2025 value amounting to $1.4 million.

  • Biomerica's Operating Expenses fell 41.96% to $1.4 million in Q4 2025 from the same period last year, while for Nov 2025 it was $5.5 million, marking a year-over-year decrease of 1497.07%. This contributed to the annual value of $5.6 million for FY2025, which is 1924.62% down from last year.
  • Per Biomerica's latest filing, its Operating Expenses stood at $1.4 million for Q4 2025, which was down 41.96% from $1.5 million recorded in Q3 2025.
  • In the past 5 years, Biomerica's Operating Expenses registered a high of $2.4 million during Q2 2022, and its lowest value of $1.2 million during Q1 2025.
  • Its 5-year average for Operating Expenses is $1.7 million, with a median of $1.8 million in 2021.
  • In the last 5 years, Biomerica's Operating Expenses surged by 8564.03% in 2021 and then tumbled by 3360.35% in 2025.
  • Biomerica's Operating Expenses (Quarter) stood at $1.9 million in 2021, then increased by 6.13% to $2.0 million in 2022, then fell by 4.21% to $1.9 million in 2023, then dropped by 26.02% to $1.4 million in 2024, then decreased by 0.42% to $1.4 million in 2025.
  • Its last three reported values are $1.4 million in Q4 2025, $1.5 million for Q3 2025, and $1.3 million during Q2 2025.